BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24929527)

  • 1. Small-molecule modulation of Ras signaling.
    Spiegel J; Cromm PM; Zimmermann G; Grossmann TN; Waldmann H
    Nat Chem Biol; 2014 Aug; 10(8):613-22. PubMed ID: 24929527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C.
    Hunter JC; Gurbani D; Ficarro SB; Carrasco MA; Lim SM; Choi HG; Xie T; Marto JA; Chen Z; Gray NS; Westover KD
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8895-900. PubMed ID: 24889603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting a Handle on RAS-targeted Therapies: Cysteine Directed Inhibitors.
    Huynh MV; Campbell SL
    Mini Rev Med Chem; 2016; 16(5):383-90. PubMed ID: 26423694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant-Specific Targeting of Ras G12C Activity by Covalently Reacting Small Molecules.
    Goody RS; Müller MP; Rauh D
    Cell Chem Biol; 2019 Oct; 26(10):1338-1348. PubMed ID: 31378709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of RAS: New hope for drugging the "undruggable".
    Khan I; Rhett JM; O'Bryan JP
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118570. PubMed ID: 31678118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
    Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
    Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators.
    Wang Y; Kaiser CE; Frett B; Li HY
    J Med Chem; 2013 Jul; 56(13):5219-30. PubMed ID: 23566315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Inhibitors of Ras-Effector Protein Interactions.
    Upadhyaya P; Bedewy W; Pei D
    Mini Rev Med Chem; 2016; 16(5):376-82. PubMed ID: 26423701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.
    Scheffzek K; Ahmadian MR; Kabsch W; Wiesmüller L; Lautwein A; Schmitz F; Wittinghofer A
    Science; 1997 Jul; 277(5324):333-8. PubMed ID: 9219684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis for the transition from Ras-GTP to Ras-GDP.
    Hall BE; Bar-Sagi D; Nassar N
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the development of Ras inhibitors.
    Shima F; Matsumoto S; Yoshikawa Y; Kawamura T; Isa M; Kataoka T
    J Biochem; 2015 Aug; 158(2):91-9. PubMed ID: 26100833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renaissance of Ras.
    Milroy LG; Ottmann C
    ACS Chem Biol; 2014 Nov; 9(11):2447-58. PubMed ID: 25148694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras signalling. Caught in the act of the switch-on.
    Wittinghofer F
    Nature; 1998 Jul; 394(6691):317, 319-20. PubMed ID: 9690464
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of Ras-SOS Interactions.
    Lu S; Jang H; Zhang J; Nussinov R
    ChemMedChem; 2016 Apr; 11(8):814-21. PubMed ID: 26630662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RasIns: Genetically Encoded Intrabodies of Activated Ras Proteins.
    Cetin M; Evenson WE; Gross GG; Jalali-Yazdi F; Krieger D; Arnold D; Takahashi TT; Roberts RW
    J Mol Biol; 2017 Feb; 429(4):562-573. PubMed ID: 27865780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in cancer drug discovery targeting RAS.
    Wilson CY; Tolias P
    Drug Discov Today; 2016 Dec; 21(12):1915-1919. PubMed ID: 27506872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, Present, and Future of Targeting Ras for Cancer Therapies.
    Tan Z; Zhang S
    Mini Rev Med Chem; 2016; 16(5):345-57. PubMed ID: 26423695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Approaches to RAS Mutation.
    Scott AJ; Lieu CH; Messersmith WA
    Cancer J; 2016; 22(3):165-74. PubMed ID: 27341593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a peptidic ligand for Ras.
    Gareiss PC; Schneekloth AR; Salcius MJ; Seo SY; Crews CM
    Chembiochem; 2010 Mar; 11(4):517-22. PubMed ID: 20082398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Ras-related proteins talk to their effectors.
    Wittinghofer A; Nassar N
    Trends Biochem Sci; 1996 Dec; 21(12):488-91. PubMed ID: 9009833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.